Optimizing Neoral therapeutic drug monitoring with cyclosporine trough (C0) and C2 concentrations in stable renal allograft recipients

Transplantation Proceedings

Volumn 33, Issue 7-8, 2001, Pages 3102-3103

  Einecke, G ^a   Mai, I ^a   Diekmann, F ^a   Fritsche, L ^a   Boehler, T ^a   Neumayer, H H ^a   Budde, K ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MONOCLONAL ANTIBODY;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG MONITORING; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PRIORITY JOURNAL; VALIDATION PROCESS;

ADMINISTRATION, ORAL; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL ABSORPTION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035678101     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(01)02322-3     Document Type: Article

References (9)

1. Kahan BD, Grevel J: Transplantation 46:631, 1988
2. Kaiske BL, Heim-Duthoy K, Rao KV, et al: Transplantation 46:716, 1988
3. Meyer MM, Muner M, Udeaja J, et al: J Am Soc Nephrol 4:1306, 1993
4. Kahan BD, Welsh M, Rutzky LP: Ther Drug Monit 17:621, 1995
5. David OJ, Johnston A: Ther Drug Monit 23:100, 2001
6. Keown P, Landsberg D, Halloran P, et al: Transplantation 62:1744, 1996
7. Gaspari F, Perico N, Signorini O, et al: Kidney Int 54:2146, 1998
8. Cole E, et al: Am J Transplant I(suppl 1):386, 2001
9. Levy GA: BioDrugs 15:279, 2001